Cargando…
Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma
BACKGROUND: Histological analysis has revealed the need for new treatment techniques for epithelial ovarian cancer. Immune checkpoint inhibitors may be a new therapeutic strategy for ovarian clear cell carcinoma (OCCC). Lymphocyte-activation gene 3 (LAG-3), an immune checkpoint, is a poor prognostic...
Autores principales: | Zaitsu, Sumika, Yano, Mitsutake, Adachi, Sawako, Miwa, Maiko, Katoh, Tomomi, Kawano, Yasushi, Yasuda, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182671/ https://www.ncbi.nlm.nih.gov/pubmed/37179337 http://dx.doi.org/10.1186/s13048-023-01179-1 |
Ejemplares similares
-
Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
por: Yano, Mitsutake, et al.
Publicado: (2019) -
Tumor-to-tumor metastasis from appendiceal adenocarcinoma to an ovarian mature teratoma, mimicking malignant transformation of a teratoma: a case report
por: Yano, Mitsutake, et al.
Publicado: (2019) -
A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma
por: Heong, Valerie, et al.
Publicado: (2021) -
Immune checkpoint inhibitors of CTLA4 and PD-1 for malignant melanoma arising in ovarian cystic teratoma: A case report
por: Yano, Mitsutake, et al.
Publicado: (2018) -
A unique uterine cervical “teratocarcinosarcoma”: a case report
por: Ito, Kozue, et al.
Publicado: (2019)